StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 6/30
$5.57−1.11 (-16.62%)

Close on Nov 16, 2026Market cap $59.80MP/E –Yield –

PharmaCyte Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

PharmaCyte Biotech's enterprise value was -$13.55M on Nov 11, 2026, against -$10.28M a year earlier. Over the last 5 years it ranged from -$56.23M to -$8.12M, with a median of -$19.47M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$13.55M–
2025Dec 31, 2025-$10.30M–
2024Dec 31, 2024-$9.80M–
2023Dec 29, 2023-$54.63M–
2022Dec 30, 2022-$19.75M–
2021Dec 31, 2021-$35.15M-382.4%
2020Dec 31, 2020$12.45M-77.7%
2019Dec 31, 2019$55.69M+37.7%
2018Dec 31, 2018$40.44M-24.3%
2017Dec 29, 2017$53.43M-58.6%
2016Dec 30, 2016$129.10M+288.7%
2015Dec 31, 2015$33.22M-74.1%
2014Dec 31, 2014$128.32M+108.2%
2013Dec 31, 2013$61.62M–

More PharmaCyte Biotech figures

See a number that looks wrong?